← All American Well CORP filings

American Well CORP DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
AMWL
American Well CORP
DEF: Amwell's 2026 Annual Meeting: Focus on Strategy and Governance
American Well Corporation announces its 2026 Annual Meeting of Stockholders, highlighting strategic progress, financial performance, and corporate governance matters.
NYSE
AMWL
American Well CORP
DEFA14A: American Well Corporation Announces Annual Meeting and Proxy Voting Details
American Well Corporation (Amwell) has announced its annual meeting of stockholders to be held on June 18, 2024, and is providing details on how stockholders can vote on key proposals.
NYSE
AMWL
American Well CORP
DEF: Amwell Corporation Aims for Profitability by 2026 Amidst Strategic Realignment
Amwell Corporation outlines its strategic focus on growth, recurring revenue, and efficiency to achieve positive cash flow by 2026, leveraging its unified technology-enabled care platform.
NYSE
AMWL
American Well CORP
DEFA14A: American Well Corporation (Amwell) to Hold Annual Meeting, Seeks Stockholder Approval for Key Proposals
American Well Corporation (Amwell) is holding its annual meeting on June 18, 2024, seeking stockholder approval for the election of directors, ratification of the auditor, executive compensation, and a reverse stock split.
NYSE
AMWL
American Well CORP
DEF 14A: Amwell Outlines Strategic Priorities for 2024, Focuses on Profitable Growth and Platform Migration
Amwell's proxy statement highlights the company's strategic achievements in 2023, including platform migration and market wins, while outlining priorities for 2024 focused on profitable growth and continued platform development.